Physician profile
William P Mcguinn
NPI 1851370175
$1,120.78
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $43.01 · 2021: $190 · 2022: $24.76 · 2023: $372 · 2024: $22.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $285.37 | 2019-2024 | Camzyos, Cobenfy |
| Heartflow, INC. | $139.77 | 2023 | Ffrct |
| Pfizer INC. | $133.70 | 2019 | |
| Janssen Pharmaceuticals, INC | $125.59 | 2019 | |
| Abbott Laboratories | $109.26 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astellas Pharma US INC | $89.00 | 2021 | |
| Boston Scientific Corporation | $81.34 | 2019-2022 | |
| Amgen INC. | $41.16 | 2019-2021 | |
| Lundbeck LLC | $31.55 | 2019-2020 | |
| Amarin Pharma, INC. | $29.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.96 | 2021 | |
| Philips North America LLC | $14.86 | 2020 | |
| Medtronic Vascular, INC. | $11.30 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcguinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.